Graviti Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GRAVITI PHARMS, and what generic and branded alternatives to GRAVITI PHARMS drugs are available?
GRAVITI PHARMS has seventeen approved drugs.
There is one tentative approval on GRAVITI PHARMS drugs.
Drugs and US Patents for Graviti Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Graviti Pharms | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 209912-002 | Jun 18, 2018 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Graviti Pharms | MONTELUKAST SODIUM | montelukast sodium | TABLET;ORAL | 209012-001 | Apr 24, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Graviti Pharms | FAMOTIDINE | famotidine | TABLET;ORAL | 218181-002 | Dec 22, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.